ADIL
Adial Pharmaceuticals Inc
NASDAQ: ADIL · HEALTHCARE · BIOTECHNOLOGY
$1.55
-0.64% today
Updated 2026-04-29
Market cap
$2.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.93
Dividend yield
—
52W range
$2 – $30
Volume
0.1M
Adial Pharmaceuticals Inc (ADIL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $216225.00 | $151526.00 | $34546.00 | $4.70M | $7.68M | $5.49M | $7.63M | $5.73M | $4.74M | $5.04M |
| Cash & equivalents | $162377.00 | $87993.00 | $18248.00 | $3.87M | $6.78M | $4.40M | $6.06M | $4.00M | $2.83M | $3.75M |
| Current assets | $205547.00 | $141413.00 | $27248.00 | $4.69M | $7.67M | $5.14M | $6.46M | $4.78M | $3.20M | $4.06M |
| Total liabilities | $53080.00 | $255019.00 | $1.03M | $257974.00 | $539051.00 | $1.51M | $4.13M | $2.46M | $653513.00 | $975858.00 |
| Current liabilities | $53080.00 | $255019.00 | $1.03M | $257974.00 | $539051.00 | $1.51M | $2.72M | $1.79M | $653076.00 | $975858.00 |
| Long-term debt | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $163145.00 | $-103493.00 | $-997553.00 | $4.44M | $7.14M | $3.99M | $3.51M | $3.28M | $4.08M | $4.07M |
| Retained earnings | $-9.52M | $-9.94M | $-403992.00 | $-12.04M | $-20.63M | $-31.52M | $-50.94M | $-63.67M | $-68.80M | $-82.00M |
| Accounts receivable | — | $35117.00 | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | $0.00 | $248971.00 | $248971.00 | — | — |